Krieger SC - Search Results

1

Detection of subtle gait disturbance and future fall risk in early multiple sclerosis.

Brandstadter R, Ayeni O, Krieger SC, Harel NY, Escalon MX, Katz Sand I, Leavitt VM, Fabian MT, Buyukturkoglu K, Klineova S, Riley CS, Lublin FD, Miller AE, Sumowski JF. Brandstadter R, et al. Among authors: krieger sc. Neurology. 2020 Mar 31;94(13):e1395-e1406. doi: 10.1212/WNL.0000000000008938. Epub 2020 Feb 26. Neurology. 2020. PMID: 32102980 Free PMC article.

2

Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME.

Miller AE, Cohen BA, Krieger SC, Markowitz CE, Mattson DH, Tselentis HN. Miller AE, et al. Among authors: krieger sc. Mult Scler. 2014 Jan;20(1):18-23. doi: 10.1177/1352458513495937. Epub 2013 Aug 6. Mult Scler. 2014. PMID: 23921134 Free article.

3

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.

Katz Sand I, Krieger S, Farrell C, Miller AE. Katz Sand I, et al. Mult Scler. 2014 Oct;20(12):1654-7. doi: 10.1177/1352458514521517. Epub 2014 Feb 3. Mult Scler. 2014. PMID: 24493475

4

Emergency medical care of multiple sclerosis patients: primary data from the mount sinai resource utilization in multiple sclerosis project.

Oynhausen S, Alcauskas M, Hannigan C, Bencosme Y, Müller M, Lublin F, Krieger S. Oynhausen S, et al. J Clin Neurol. 2014 Jul;10(3):216-21. doi: 10.3988/jcn.2014.10.3.216. Epub 2014 Jul 3. J Clin Neurol. 2014. PMID: 25045374 Free PMC article.

5

Clinical course in multiple sclerosis patients presenting with a history of progressive disease.

Pandey KS, Krieger SC, Farrell C, Hannigan C, DeAngelis T, Miller AE, Lublin FD. Pandey KS, et al. Among authors: krieger sc. Mult Scler Relat Disord. 2014 Jan;3(1):67-71. doi: 10.1016/j.msard.2013.05.004. Epub 2013 Jul 19. Mult Scler Relat Disord. 2014. PMID: 25877975

6

Alemtuzumab in multiple sclerosis: an update.

Gross RH, Krieger S. Gross RH, et al. Neurodegener Dis Manag. 2015;5(3):225-32. doi: 10.2217/nmt.15.14. Neurodegener Dis Manag. 2015. PMID: 26107321 Review.

7

Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.

Ruggieri S, Petracca M, Miller A, Krieger S, Ghassemi R, Bencosme Y, Riley C, Howard J, Lublin F, Inglese M. Ruggieri S, et al. JAMA Neurol. 2015 Dec;72(12):1466-74. doi: 10.1001/jamaneurol.2015.1897. JAMA Neurol. 2015. PMID: 26457955

8

Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?

Petracca M, Cordano C, Cellerino M, Button J, Krieger S, Vancea R, Ghassemi R, Farrell C, Miller A, Calabresi PA, Lublin F, Inglese M. Petracca M, et al. Mult Scler. 2017 Jan;23(1):43-50. doi: 10.1177/1352458516637679. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 26993116

9

Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note.

Wang G, Cutter GR, Cofield SS, Lublin F, Wolinsky JS, Gustafson T, Krieger S, Salter A. Wang G, et al. Mult Scler. 2017 Jun;23(7):982-987. doi: 10.1177/1352458516670733. Epub 2016 Sep 28. Mult Scler. 2017. PMID: 27682227 Free PMC article. Clinical Trial.

10

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.

Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page